Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 416Thoracic 5Gastrointestinal 2Lymphoid 1Breast 1

Conditions

Breast Neoplasms 10163Triple Negative Breast Neoplasms 1042Neoplasms 572Ovarian Neoplasms 560Neoplasm Metastasis 513Colorectal Neoplasms 467Carcinoma, Non-Small-Cell Lung 465Prostatic Neoplasms 439Lung Neoplasms 432Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 294Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 225Endometrial Neoplasms 221Head and Neck Neoplasms 217Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 191Squamous Cell Carcinoma of Head and Neck 179Sarcoma 175Urinary Bladder Neoplasms 159Brain Neoplasms 155Esophageal Neoplasms 154Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 128

Interventions

abemaciclib 1Letrozole 1Hydroxychloroquine 1Fulvestrant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Solid Tumor × Breast × Clear all
NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Medical College of Wisconsin

Phase 1 Withdrawn
BreastOther solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡